Table 3.
Author | Drug | Design | No. of patients | Reference |
---|---|---|---|---|
Fautrel et al. | MTX | Retrospective, uncontrolled | 26 | [37] |
Kalyonku et al. | MTX | Prospective multicentre | 202 | [38] |
Pay et al. | MTX | Retrospective multicentre | 61 | [39] |
Iliou et al. | MTX | Retrospective, uncontrolled | 11 | [40] |
Franchini et al. | MTX | Retrospective monocentre | 27 (five combination of DMARDs) | [41] |
Fuji et al. | MTX | Retrospective monocentre | 13 | [42] |
Singh et al. | MTX | Retrospective | 10 | [43] |
Nordström et al. | MTX | RCT | 6 | [44] |
Woo et al. | MTX | RCT | 45 | [45] |
Aydintug et al. | MTX | Case series | 6 | [46] |
Manger et al. | MTX | Review | 71 | [47] |
Wang et al. | MTX | Prospective | 28 | [54] |
AOSD: adult-onset Still’s disease.